VIRIVEA
LIVE

Serial Number

79412673

Owner

Lehmann & Voss & Co. KG

Attorney

Donna J. Bunton

Filing Date

Oct 30, 2024

Add to watchlist:

No watchlists yet
View on USPTO

VIRIVEA Trademark

Serial Number: 79412673

VIRIVEA is a trademark filed by Lehmann & Voss & Co. KG on October 30, 2024. The trademark is classified under Class 1 (Chemicals). The application is currently pending registration.

Owner Contact Info

Lehmann & Voss & Co. KG (22 trademarks)

Alsterufer 19
20354 Hamburg , DE

Entity Type: 13

Trademark Details

Filing Date

October 30, 2024

Registration Date

Not Registered

Published for Opposition

January 27, 2026

Goods & Services

Chemical additives for the manufacture of cosmetics; plant extracts, other than essential oils, for industrial purposes; plant extracts, other than essential oils, for use in the manufacture of cosmetics

Filing History

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Jan 27, 2026 NPUB
PUBLISHED FOR OPPOSITION
Jan 27, 2026 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Jan 21, 2026 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 5, 2026 CNSA
EXAMINER'S AMENDMENT ENTERED
Jan 5, 2026 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Jan 5, 2026 GNEN
EXAMINERS AMENDMENT E-MAILED
Jan 5, 2026 GNEA
EXAMINERS AMENDMENT -WRITTEN
Jan 5, 2026 CNEA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 11, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 11, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 11, 2025 TROA
REFUSAL PROCESSED BY IB
Jun 27, 2025 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Jun 12, 2025 RFCS
REFUSAL PROCESSED BY MPU
Jun 12, 2025 RFRR
LIMITATION OF GOODS RECEIVED FROM IB
May 30, 2025 LIMG
LIMITATION OF GOODS RECEIVED FROM IB
Apr 11, 2025 LIMG
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Apr 9, 2025 RFCR
NON-FINAL ACTION WRITTEN
Apr 8, 2025 CNRT
ASSIGNED TO EXAMINER
Mar 27, 2025 DOCK
APPLICATION FILING RECEIPT MAILED
Dec 20, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 20, 2024 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Dec 19, 2024 REPR